Insider filing · RARE
Howard Horn
Chief Financial Officer
profile →
Ultragenyx Pharmaceutical Inc.
RARE · Healthcare · 27 filings in 24 months
ticker →
Howard Horn sold $250K of Ultragenyx Pharmaceutical (RARE)
Executed Oct 13 2025, disclosed Oct 14 2025, 1 day later.
Value, as filed
$250K
7,942 sh × $31.51
Executed
Oct 13 2025
the trade date, as filed
Disclosed
Oct 14 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
HHHoward Horn (Chief Financial Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Ultragenyx Pharmaceutical Inc. (RARE). The largest single filing was $250K of RARE (7,942 sh × $31.51, as filed), executed Oct 13 2025.
The name
RAREHealthcare · Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Howard Horn in RARE
RARESALE
Ultragenyx Pharmaceutical Inc.
$117K4,696 sh × $24.92
Exec Aug 3
Filed Aug 4 · 3:13 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $156K
4,698 sh × $33.13
Exec Jul 1
Filed Jul 6 · 3:37 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $111K
4,653 sh × $23.77
Exec Jun 1
Filed Jun 1 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $117K
4,683 sh × $24.90
Exec May 1
Filed May 4 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $121K
5,290 sh × $22.80
Exec Mar 2
Filed Mar 3 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $112K
3,081 sh × $36.38
Exec Dec 10 2025
Filed Dec 11 2025 · 5:30 PM ET RARESALE Ultragenyx Pharmaceutical Inc. $394K
7,465 sh × $52.76
Exec Oct 10 2024
Filed Oct 11 2024 · 5:30 PM ET